Oncotelic Therapeutics, Inc. (OTLC) stock
OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02+0.00 (+11.45%)
Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –
Oncotelic Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Oncotelic Therapeutics's operating cash flow for the twelve months ending Jun 30, 2025 was -$540.19K. For fiscal 2025 it was -$1.38M. The highest annual figure on record is -$240.98K in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.38M | – |
| FY2024 | Dec 31, 2024 | -$740.28K | – |
| FY2023 | Dec 31, 2023 | -$1.32M | – |
| FY2022 | Dec 31, 2022 | -$1.45M | – |
| FY2021 | Dec 31, 2021 | -$4.43M | – |
| FY2020 | Dec 31, 2020 | -$2.81M | – |
| FY2019 | Dec 31, 2019 | -$2.28M | – |
| FY2018 | Dec 31, 2018 | -$240.98K | – |
| FY2017 | Dec 31, 2017 | -$10.93M | – |
| FY2016 | Dec 31, 2016 | -$15.24M | – |
| FY2015 | Dec 31, 2015 | -$11.93M | – |
| FY2014 | Dec 31, 2014 | -$12.15M | – |
| FY2013 | Dec 31, 2013 | -$7.00M | – |
| FY2012 | Dec 31, 2012 | -$8.34M | – |
| FY2011 | Dec 31, 2011 | -$11.78M | – |
| FY2010 | Dec 31, 2010 | -$20.43M | – |
| FY2009 | Dec 31, 2009 | -$28.67M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$92.20K | – |
| Q1 FY2026 | Mar 31, 2026 | -$342.24K | – |
| Q2 FY2025 | Jun 30, 2025 | -$126.15K | – |
| Q1 FY2025 | Mar 31, 2025 | -$166.96K | – |
| Q4 FY2024 | Dec 31, 2024 | -$103.89K | – |
| Q3 FY2024 | Sep 30, 2024 | -$143.20K | – |
| Q2 FY2024 | Jun 30, 2024 | -$261.77K | – |
| Q1 FY2024 | Mar 31, 2024 | -$231.42K | – |
| Q4 FY2023 | Dec 31, 2023 | -$372.62K | – |
| Q3 FY2023 | Sep 30, 2023 | -$248.85K | – |
| Q2 FY2023 | Jun 30, 2023 | -$448.56K | – |
| Q1 FY2023 | Mar 31, 2023 | -$251.02K | – |
| Q4 FY2022 | Dec 31, 2022 | -$80.68K | – |
| Q3 FY2022 | Sep 30, 2022 | -$206.08K | – |
| Q2 FY2022 | Jun 30, 2022 | -$203.13K | – |
| Q1 FY2022 | Mar 31, 2022 | -$962.67K | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.07M | – |
| Q3 FY2021 | Sep 30, 2021 | -$900.69K | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.21M | -633.9% |
| Q1 FY2021 | Mar 31, 2021 | -$1.25M | -4076.4% |
| Q4 FY2020 | Dec 31, 2020 | -$1.49M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.58M | – |
| Q2 FY2020 | Jun 30, 2020 | $227.47K | – |
| Q1 FY2020 | Mar 31, 2020 | $31.47K | – |
| Q4 FY2019 | Dec 31, 2019 | -$944.40K | – |
| Q3 FY2019 | Sep 30, 2019 | -$443.07K | – |
| Q2 FY2019 | Jun 30, 2019 | -$775.23K | -188.9% |
| Q1 FY2019 | Mar 31, 2019 | -$118.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$40.05K | – |
| Q3 FY2018 | Sep 30, 2018 | -$191.03K | – |
| Q2 FY2018 | Jun 30, 2018 | $872.10K | – |
| Q1 FY2018 | Mar 31, 2018 | -$882.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$793.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.10M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.34M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.70M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.23M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.06M | – |
| Q2 FY2016 | Jun 30, 2016 | -$3.55M | – |
See a number that looks wrong?